Investors / Foresite Capital / Compare with The Column Group

Foresite Capital vs The Column Group

Foresite Capital lists 143 portfolio companies and has joined 17 funding rounds; The Column Group lists 37 companies and has joined 11 rounds. Foresite Capital comes in most often at Series A (38% of its entries), The Column Group comes in most often at Growth (44% of its entries). 7 companies are on both portfolios, among them Arcus Biosciences, Inc., Eikon Therapeutics and Ngm Bio.

Foresite CapitalView profilevsThe Column GroupView profile

143Portfolio companies37

17Funding rounds joined11

1Rounds led9

10Rounds, last 12 months9

$20M to $100MTypical round it comes in at$100M or more

0%Sites no longer answering0%

Show as a table

Foresite Capital and The Column Group, head to head

	Foresite Capital	The Column Group
Portfolio companies	143	37
Funding rounds joined	17	11
Rounds led	1	9
Rounds, last 12 months	10	9
Typical round it comes in at	$20M to $100M	$100M or more
Sites no longer answering	0%	0%

Companies both back

7

Arcus Biosciences, Inc.arcusbio.comEikon Therapeuticseikontx.comNgm Biongmbio.comNurixnurixtx.comPeloton Therapeuticspelotontherapeutics.comRAPTrapt.comRemix Therapeuticsremixtx.com

Shared companies are those both firms' own portfolio pages list, each checked against the company's site. The same comparison through the API is POST /v1/overlap, for up to 20 firms. How the data is graded

$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/foresitecapital.com/portfolio

# also
GET /v1/firms/thecolumngroup.com/portfolio
GET /v1/firms/foresitecapital.com/coinvestors